CD200 Upregulation in Vascular Endothelium Surrounding Cutaneous Squamous Cell Carcinoma

被引:27
作者
Belkin, Daniel A. [1 ]
Mitsui, Hiroshi [3 ]
Wang, Claire Q. F. [3 ]
Gonzalez, Juana [4 ]
Zhang, Shali [5 ]
Shah, Kejal R. [3 ]
Coats, Israel [3 ]
Suarez-Farinas, Mayte [3 ]
Krueger, James G. [3 ]
Felsen, Diane [2 ]
Carucci, John A. [5 ]
机构
[1] Weill Cornell Med Coll, Dept Dermatol, New York, NY USA
[2] Weill Cornell Med Coll, Dept Urol, Inst Pediat Urol, New York, NY USA
[3] Rockefeller Univ, Invest Dermatol Lab, New York, NY 10021 USA
[4] Rockefeller Univ, Ctr Clin & Translat Sci, New York, NY 10021 USA
[5] NYU, Langone Med Ctr, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA
关键词
RECEPTOR ENGAGEMENT; THERAPEUTIC TARGET; DENDRITIC CELLS; TUMOR-CELLS; EXPRESSION; CANCER; MICROENVIRONMENT; LOCALIZATION; MACROPHAGES; ACTIVATION;
D O I
10.1001/jamadermatol.2013.1609
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To characterize the presence of CD200 and CD200 receptor (CD200R) in the human cutaneous squamous cell carcinoma (SCC) microenvironment and to define a possible role for the CD200 axis in immune evasion by SCC. Design: Gene expression in SCC vs normal skin was studied. Laser capture microdissection was used to determine differential expression of CD200 in normal skin vs actinic keratosis vs SCC in situ vs invasive SCC. Immunofluorescence microscopy was used to define expression of CD200R on macrophages, myeloid dendritic cells, natural killer cells, and T cells in SCC vs normal skin. The effects of SCC supernatant on induction of CD200 in human blood endothelial cells was also examined. Setting: Academic Medical Center with an established Section of Mohs and Dermatologic Surgery and an active Cutaneous Biology Research Program. Participants: Surgical discard tissue from deidentified patients and samples of normal skin from healthy volunteers were used in this study. Main Outcome Measures: Expression of CD200 on SCC-associated blood vessels; expression of CD200 receptor on SCC-associated macrophages and T cells; and induction of CD200 on endothelial cells by SCC supernatants. Results: CD200 gene and message were upregulated in SCC stroma. Immunostaining revealed a higher number of CD200(+) cells in SCC stroma than in normal dermis (180.8 cells/mm(2) vs 24.6 cells/mm(2)) (P < .01). CD200 was further identified mainly on blood vessel endothelium in SCC. Tumor supernatant was able to induce CD200 expression on human dermal blood endothelial cells in culture. CD200R was identified on macrophages and dendritic cells in SCC microenvironment. Conclusions: CD200 expression on local blood vessels may promote tumor progression by suppressing CD200R(+) myeloid cells during diapedesis. These data highlight a previously unrecognized mechanism of immune evasion by SCC and may provide guidance for the development of targeted therapy. JAMA Dermatol. 2013;149(2):178-186. Published online December 17, 2012. doi: 10.1001/jamadermatol.2013.1609
引用
收藏
页码:178 / 186
页数:9
相关论文
共 41 条
  • [1] BARCLAY AN, 1981, IMMUNOLOGY, V44, P727
  • [2] Myeloid Dendritic Cells from Human Cutaneous Squamous Cell Carcinoma Are Poor Stimulators of T-Cell Proliferation
    Bluth, Mark J.
    Zaba, Lisa C.
    Moussai, Dariush
    Suarez-Farinas, Mayte
    Kaporis, Helen
    Fan, Linda
    Pierson, Katherine C.
    White, Traci R.
    Pitts-Kiefer, Alexander
    Fuentes-Duculan, Judilyn
    Guttman-Yassky, Emma
    Krueger, James G.
    Lowes, Michelle A.
    Carucci, John A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (10) : 2451 - 2462
  • [3] Analysis of risk factor's determining prognosis of cutaneous squamous-cell carcinoma:: a prospective study
    Brantsch, Kay D.
    Meisner, Christoph
    Schoenfisch, Birgitt
    Trilling, Birgit
    Wehner-Caroli, Joerg
    Roecken, Martin
    Breuninger, Helmut
    [J]. LANCET ONCOLOGY, 2008, 9 (08) : 713 - 720
  • [4] Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis
    Broderick, C
    Hoek, RM
    Forrester, JV
    Liversidge, J
    Sedgwick, JD
    Dick, AD
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 161 (05) : 1669 - 1677
  • [5] BUKOVSKY A, 1983, IMMUNOLOGY, V48, P587
  • [6] NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia
    Dajee, M
    Lazarov, M
    Zhang, JY
    Cai, T
    Green, CL
    Russell, AJ
    Marinkovich, MP
    Tao, SY
    Lin, Q
    Kubo, Y
    Khavari, PA
    [J]. NATURE, 2003, 421 (6923) : 639 - 643
  • [7] Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement
    Fallarino, F
    Asselin-Paturel, C
    Vacca, C
    Bianchi, R
    Gizzi, S
    Fioretti, MC
    Trinchieri, G
    Grohmann, U
    Puccetti, P
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (06) : 3748 - 3754
  • [8] Stromal Endothelial Cells Directly Influence Cancer Progression
    Franses, Joseph W.
    Baker, Aaron B.
    Chitalia, Vipul C.
    Edelman, Elazer R.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (66)
  • [9] A Subpopulation of CD163-Positive Macrophages Is Classically Activated in Psoriasis
    Fuentes-Duculan, Judilyn
    Suarez-Farinas, Mayte
    Zaba, Lisa C.
    Nograles, Kristine E.
    Pierson, Katherine C.
    Mitsui, Hiroshi
    Pensabene, Cara A.
    Kzhyshkowska, Julia
    Krueger, James G.
    Lowes, Michelle A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (10) : 2412 - 2422
  • [10] Receptor engagement on cells expressing a ligand for the tolerance-inducing molecule OX2 induces an immunoregulatory population that inhibits alloreactivity in vitro and in vivo
    Gorczynski, RM
    Yu, K
    Clark, D
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (09) : 4854 - 4860